T. Lüscher in conversation with W. Boden and P. Barter: AIM-HIGH- Extended-Release Niacin Does Not Reduce Clinical Events in Patients with Established Cardiovascular Disease Whose LDL-Cholesterol is Optimally Controlled with Statin Therapy.
T. Lüscher in conversation with S. Goldhaber and M. Cushman: ADOPT- Extended Anticoagulant Prophylaxis in Initially Hospitalized Medically Ill Patients: Results of the ADOPT Trial
T. Lüscher in conversation with J. Spertus and M. Patel: PRISM- Testing an Evidence-Based, Individualized Informed Consent Form to Improve Patients' Experiences with PCI
T. Lüscher in conversation with K. Mahaffey and K. Fox: TRACER- The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome
T. Lüscher in conversation with J. Nielsen and W. Stevenson: MANTRA PAF- A Randomized Multicenter Comparison of Radiofrequency Ablation and Antiarrhythmic Drug Therapy as First-Line Treatment in 294 Patients with Paroxysmal Atrial Fibrillation
